Prospects for antibacterial discovery and development

TM Privalsky, AM Soohoo, J Wang… - Journal of the …, 2021 - ACS Publications
The rising prevalence of multidrug-resistant bacteria is an urgent health crisis that can only
be countered through renewed investment in the discovery and development of antibiotics …

Anti-tuberculosis Mur inhibitors: structural insights and the way ahead for development of novel agents

K Mehta, M Khambete, A Abhyankar, A Omri - Pharmaceuticals, 2023 - mdpi.com
Mur enzymes serve as critical molecular devices for the synthesis of UDP-MurNAc-
pentapeptide, the main building block of bacterial peptidoglycan polymer. These enzymes …

The mur enzymes chink in the armour of Mycobacterium tuberculosis cell wall

Y Shinde, I Ahmad, S Surana, H Patel - European Journal of Medicinal …, 2021 - Elsevier
Tuberculosis (TB) transmitted by Mycobacterium tuberculosis (Mtb) is one of the top 10
causes of death globally. Currently, the widespread occurrence of resistance toward Mtb …

Computational target-based screening of anti-MRSA natural products reveals potential multitarget mechanisms of action through peptidoglycan synthesis proteins

SO Oselusi, AO Fadaka, GJ Wyckoff, SA Egieyeh - ACS omega, 2022 - ACS Publications
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading causes of bacterial
infections in both healthcare and community settings. MRSA can acquire resistance to any …

[HTML][HTML] Screening and molecular dynamics simulation of compounds inhibiting MurB enzyme of drug-resistant Mycobacterium tuberculosis: An in-silico approach

A Verma, V Kumar, B Naik, JM Khan, P Singh… - Saudi journal of …, 2023 - Elsevier
Mycobacterium tuberculosis (MTB) is becoming more and more resistant to drugs and it is a
common problem, making current antimicrobials ineffective and highlighting the need for …

Recent progress in the development of novel mycobacterium cell wall inhibitor to combat drug-resistant tuberculosis

TM Belete - Microbiology Insights, 2022 - journals.sagepub.com
Despite decades of research in drug development against TB, it is still the leading cause of
death due to infectious diseases. The long treatment duration, patient noncompliance …

Emerging extracellular molecular targets for innovative pharmacological approaches to resistant Mtb infection

A Italia, MM Shaik, F Peri - Biomolecules, 2023 - mdpi.com
Emerging pharmacological strategies that target major virulence factors of antibiotic-
resistant Mycobacterium tuberculosis (Mtb) are presented and discussed. This review is …

Design and Synthesis of Various 5′-Deoxy-5′-(4-Substituted-1,2,3-Triazol-1-yl)-Uridine Analogues as Inhibitors of Mycobacterium tuberculosis Mur Ligases

V Hervin, R Arora, J Rani, S Ramchandran, U Bajpai… - Molecules, 2020 - mdpi.com
The synthesis of hitherto unknown 5′-deoxy-5′-(4-substituted-1, 2, 3-triazol-1-yl)-uridine
and its evaluation, through an one-pot screening assay, against MurA-F enzymes involved …

A high content screening assay for discovery of antimycobacterial compounds based on primary human macrophages infected with virulent Mycobacterium …

S Kalsum, M Otrocka, B Andersson, A Welin, T Schön… - Tuberculosis, 2022 - Elsevier
Drug resistance in Mycobacterium tuberculosis is an emerging threat that makes the
discovery of new candidate drugs a priority. In particular, drugs with high sterilizing activity …

Screening of potential phytomolecules against MurG as drug target in nosocomial pathogen Pseudomonas aeruginosa: perceptions from computational campaign

KB Lokhande, SV Pawar, S Madkaiker… - Journal of …, 2024 - Taylor & Francis
The nosocomial infection outbreak caused by Pseudomonas aeruginosa remains a public
health concern. Multi-drug resistant (MDR) strains of P. aeruginosa are rapidly spreading …